Skip to main content
. 2022 Mar 9;13:848472. doi: 10.3389/fphar.2022.848472

TABLE 8.

The signals of ADRs (4 methods, TOP10 and off-label).

Drug ADR ROR (LI95) PRR PRR (LI95) χ2 IC(LI95)
perphenazine Tongue induration 4.34 15.51 4.36 21.05 2.23
sulpiride Insomnia 5.70 13.29 5.60 45.33 2.34
chlorpromazine Blood pressure decreased 3.55 11.81 3.58 17.01 2.07
chlorpromazine Orthostatic hypotension 4.79 10.63 4.70 37.87 2.17
chlorpromazine Pruritus 3.38 11.19 3.41 16.04 2.01
haloperidol Dystonia 6.66 9.54 6.14 136.25 2.05
olanzapine Obesity 2.13 8.48 2.13 9.36 0.78
amisulpride Pollakiuriaa 2.00 7.95 2.00 7.74 1.03
chlorpromazine Rash 2.74 7.46 2.76 14.91 1.62
haloperidol Nuchal rigidity 2.57 7.32 2.57 14.50 1.21
ziprasidone Dyspnoeaa 1.64 5.07 1.65 7.27 0.77
quetiapine Urinary incontinencea 1.41 5.28 1.41 4.62 0.65
olanzapine Hepatic function abnormala 2.17 3.18 2.12 33.54 0.80

The superscript a represents off-label adverse reactions.